Regula Lustenberger

Regula Lustenberger, PhD, has extensive experience in the fields of neurobiology, clinical research, and medical affairs. Lustenberger served as a PhD student at the University of Basel from May 2008 to July 2012, followed by a postdoctoral position at the same institution for a brief period. Lustenberger then transitioned to the Swiss Group for Clinical Cancer Research (SAKK), holding roles as Head of Monitoring ad interim and CRA Level III. Lustenberger further developed a career at Pfizer between April 2016 and May 2019, where responsibilities included Medical Advisor for Biosimilars, Inflammation & Immunology, and Antivirals, as well as Regulatory Affairs Manager. Additionally, Lustenberger pursued professional development through clinical monitoring and project management training at ECCRT. Lustenberger earned a Master of Science degree in Neurobiology and Neurosciences from the University of Zürich prior to obtaining a PhD from the University of Basel's Biozentrum.